Vaccination with autologous dendritic cells pulsed with allogenous melanoma lysate (MelCancerVac) for treatment of patients with advanced colorectal cancer
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2009
At a glance
- Drugs Dendritic cell vaccine DanDrit Biotech (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2006 Status change
- 06 Nov 2006 New trial record.